NELSON MULLINS RILEY & SCARBOROUGH

Lobbying for ANBEX, INC. · Pharmaceutical Manufacturing

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $15,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Stockpile potassium iodide to counteract effects of nuclear radiation.

Energy/Nuclear

The utilization of potassium iodide to protect against nuclear radiation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.